Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Explore Stories | Novartis |
Description | Explore stories about how Novartis innovation has impacted people worldwide. |
Keywords | novartis, novartis stories, global impact |
WebSite | www.novartispharma.com |
Host IP | 45.60.11.232 |
Location | United States |
Site | Rank |
patientassistancenow.com | #2,561,323 |
novartisoncology.com | #2,331,984 |
ciprodex.com | #2,121,379 |
nowteam.net |
nucot.co.in |
nursingassistantguides.com |
nuskin.sharepoint.com |
nuxtpro.com |
nxtdial.com |
oasiswfs.in |
objectif-bastille.com |
oboronhim.ru |
ohayosensei.com |
easysexmarket.com |
eclipse-print.de |
US$29,844
Last updated: Jan 11, 2020
Novartispharma.com has global traffic rank of 1,716,295. Novartispharma.com has an estimated worth of US$ 29,844, based on its estimated Ads revenue. Novartispharma.com receives approximately 1,817 unique visitors each day. Its web server is located in United States, with IP address 45.60.11.232. According to SiteAdvisor, novartispharma.com is safe to visit. |
Purchase/Sale Value | US$29,844 |
Daily Ads Revenue | US$16 |
Monthly Ads Revenue | US$490 |
Yearly Ads Revenue | US$5,968 |
Daily Unique Visitors | 1,817 |
Note: All traffic and earnings values are estimates. |
Global Rank | 1,716,295 |
Delta (90 Days) | 0 |
Most Popular In Country | N/A |
Country Rank | N/A |
Host | Type | TTL | Data |
novartispharma.com | A | 21599 | IP: 45.60.11.232 |
novartispharma.com | A | 21599 | IP: 45.60.13.232 |
novartispharma.com | NS | 21599 | Target: dns4.novartis.com. |
novartispharma.com | NS | 21599 | Target: dns2.novartis.com. |
novartispharma.com | NS | 21599 | Target: dns3.novartis.com. |
novartispharma.com | NS | 21599 | Target: dns1.novartis.com. |
novartispharma.com | TXT | 21599 | TXT: QuoVadis=8c5c8859-79dc-463e-a1cb-372bd00b49ba |
novartispharma.com | TXT | 21599 | TXT: 7cdd5904eb31493b86849e2bf3213f6d |
novartispharma.com | TXT | 21599 | TXT: _globalsign-domain-verification=7sds8V_yxJs85tGBzTrGJBW_-FnpvcQ_6INfh5MCna |
novartispharma.com | SOA | 21599 | MNAME: dns1.novartis.com. RNAME: hostmaster.novartis.com. Serial: 2019103002 Refresh: 28800 Retry: 7200 Expire: 604800 Minimum TTL: 3600 |
HTTP/1.1 301 Moved Permanently Date: Sat, 11 Jan 2020 06:51:17 GMT X-Frame-Options: SAMEORIGIN X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Content-Type: text/html; charset=iso-8859-1 Location: https://www.novartispharmaceuticals.com/ Vary: Accept-Encoding Content-Length: 248 Set-Cookie: visid_incap_1358217=4nB0daxMQPOOVeY0EWP95WVwGV4AAAAAQUIPAAAAAACRjGuSyGpgzmQ+7XgYJ5XG; expires=Sat, 09 Jan 2021 08:32:51 GMT; path=/; Domain=.novartispharma.com Set-Cookie: incap_ses_635_1358217=PBjTO3zgmVer54VvX/rPCGVwGV4AAAAAKxh9W/BqaKmBquowM3cKSg==; path=/; Domain=.novartispharma.com Set-Cookie: ___utmvmpsuPvEwB=eQCzEDXSREY; path=/; Max-Age=900 Set-Cookie: ___utmvapsuPvEwB=ThvFSiO; path=/; Max-Age=900 Set-Cookie: ___utmvbpsuPvEwB=LZa XCVOYalE: Ptq; path=/; Max-Age=900 X-CDN: Incapsula X-Iinfo: 4-339558877-339559121 NNNN CT(272 -1 0) RT(1578725475470 0) q(0 17 20 0) r(23 23) U5 HTTP/2 301 date: Sat, 11 Jan 2020 06:51:19 GMT x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-content-type-options: nosniff content-type: text/html; charset=iso-8859-1 location: https://www.novartis.com/stories vary: Accept-Encoding content-length: 240 set-cookie: visid_incap_1358217=j5xV8D7+SjKxG5yAIBkBH2ZwGV4AAAAAQUIPAAAAAACGV1NKBuuoWHG0aH9cmUYz; expires=Sat, 09 Jan 2021 09:26:29 GMT; path=/; Domain=.novartispharmaceuticals.com set-cookie: incap_ses_895_1358217=CRhMIXkixmG0CsKmqK5rDGdwGV4AAAAAed/OOtjbrh+i+v4oUndEnQ==; path=/; Domain=.novartispharmaceuticals.com x-cdn: Incapsula x-iinfo: 14-409409960-409409961 NNNN CT(238 482 0) RT(1578725478103 0) q(0 0 7 0) r(9 9) U5 HTTP/2 200 date: Sat, 11 Jan 2020 06:51:21 GMT content-type: text/html; charset=utf-8 set-cookie: __cfduid=dca4dbcf40499905d941655233d2a51d31578725480; expires=Mon, 10-Feb-20 06:51:20 GMT; path=/; domain=.novartis.com; HttpOnly; SameSite=Lax; Secure x-drupal-cache: MISS x-content-type-options: nosniff x-xss-protection: 1; mode=block x-frame-options: SAMEORIGIN strict-transport-security: max-age=31536000; includeSubDomains content-language: en x-ua-compatible: IE=edge,chrome=1 link: <https://www.novartis.com/stories>; rel="canonical",<https://www.novartis.com/stories>; rel="shortlink" cache-control: public, max-age=60 last-modified: Sat, 11 Jan 2020 06:51:20 GMT expires: Sun, 19 Nov 1978 05:00:00 GMT vary: Cookie,Accept-Encoding x-request-id: v-c66bd684-343e-11ea-b344-bb4f66fbbae8 x-ah-environment: prod via: varnish x-cache: MISS cf-cache-status: EXPIRED expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 5534f62aca9e946d-NRT |
Domain Name: NOVARTISPHARMA.COM Registry Domain ID: 11748121_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2019-06-18T20:00:06Z Creation Date: 1999-10-27T12:09:24Z Registry Expiry Date: 2020-10-27T12:09:24Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ Domain Name: novartispharma.com Registry Domain ID: 11748121_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-01-10T00:10:01-0800 Creation Date: 1999-10-27T00:00:00-0700 Registrar Registration Expiration Date: 2020-10-27T00:00:00-0700 Registrar: MarkMonitor, Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895770 Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited) Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited) Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited) Domain Status: serverUpdateProhibited (https://www.icann.org/epp#serverUpdateProhibited) Domain Status: serverTransferProhibited (https://www.icann.org/epp#serverTransferProhibited) Domain Status: serverDeleteProhibited (https://www.icann.org/epp#serverDeleteProhibited) Registry Registrant ID: Registrant Name: Domain Admin Registrant Organization: Novartis AG Registrant Street: P.O. Box CH-4002, Registrant City: Basel Registrant State/Province: CH Registrant Postal Code: 4002 Registrant Country: CH Registrant Phone: +1.2083895740 Registrant Phone Ext: Registrant Fax: +1.2083895799 Registrant Fax Ext: Registrant Email: novartis.domains@markmonitor.com Admin Organization: MarkMonitor, Inc. Admin State/Province: ID Admin Country: US Tech Organization: MarkMonitor, Inc. Tech State/Province: ID Tech Country: US Name Server: dns4.novartis.com Name Server: dns2.novartis.com Name Server: dns3.novartis.com Name Server: dns1.novartis.com DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ MarkMonitor is the Global Leader in Online Brand Protection. MarkMonitor Domain Management(TM) MarkMonitor Brand Protection(TM) MarkMonitor AntiCounterfeiting(TM) MarkMonitor AntiPiracy(TM) MarkMonitor AntiFraud(TM) Professional and Managed Services Visit MarkMonitor at https://www.markmonitor.com Contact us at +1.8007459229 In Europe, at +44.02032062220 |